Skip to main content
FinSpry Logo
FinSpry
GILD logo
GILD
(NASDAQ)
Gilead Sciences, Inc.
$139.71-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Gilead Sciences (GILD) Stock Price & Financial Analysis

Gilead Sciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$138.64 - $141.34
52-Week High$157.29
52-Week Low$93.37
Open$139.61
Volume4.58M
Average Volume (3M)4.58M
Market Cap175.34B
Shares Outstanding1.25B
P/E Ratio (TTM)20.69
Forward P/E10.33
Price to Sales (P/S)5.98
Price to Book (P/B)7.78
EV/EBITDA14.98
Revenue (TTM)29.44B
Net Income (TTM)8.51B
Free Cash Flow (TTM)9.46B
EPS (TTM)$6.79
Profit Margin28.90%
Operating Margin39.65%
Return on Equity (ROE)37.62%
Debt to Equity1.09
50-Day MA$144.33
200-Day MA$124.09
52-Week Change26.08%
Annual Dividend$3.19
Dividend Yield2.27%
Payout Ratio46.97%
Last Dividend Ex-DateMar 13, 2026

Frequently Asked Questions About Gilead Sciences

What is the current stock price for GILD?

As of the latest trading session, GILD stock trades at $139.71. The 52-week range is $93.37–$157.29, with a day range of $138.64–$141.34.

What is the P/E ratio for GILD?

Gilead Sciences's trailing P/E ratio is 20.7, meaning investors pay $20.7 for every $1 of annual earnings. The forward P/E is 10.3, reflecting analyst expectations for future earnings. Gilead Sciences operates in the Healthcare sector.

Does GILD pay dividends?

Yes, Gilead Sciences pays a 2.27% annual dividend yield ($3.19 per share). The payout ratio is 47.0%. The last ex-dividend date was 2026-03-13.

What do analysts recommend for GILD?

Based on 11 analysts, the consensus for GILD is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of GILD?

Gilead Sciences's market capitalization is $175.34B, classifying it as a large-cap company. Gilead Sciences operates in the Healthcare sector within the Drug Manufacturers - General industry.